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Abstract
Background: The number of protein targets with a known or predicted tri-dimensional structure
and of drug-like chemical compounds is growing rapidly and so is the need for new therapeutic
compounds or chemical probes. Performing flexible structure-based virtual screening
computations on thousands of targets with millions of molecules is intractable to most laboratories
nor indeed desirable. Since shape complementarity is of primary importance for most protein-
ligand interactions, we have developed a tool/protocol based on rigid-body docking to select
compounds that fit well into binding sites.
Results: Here we present an efficient multiple conformation rigid-body docking approach, MS-
DOCK, which is based on the program DOCK. This approach can be used as the first step of a
multi-stage docking/scoring protocol. First, we developed and validated the Multiconf-DOCK tool
that generates several conformers per input ligand. Then, each generated conformer (bioactives
and 37970 decoys) was docked rigidly using DOCK6 with our optimized protocol into seven
different receptor-binding sites. MS-DOCK was able to significantly reduce the size of the initial
input library for all seven targets, thereby facilitating subsequent more CPU demanding flexible
docking procedures.
Conclusion: MS-DOCK can be easily used for the generation of multi-conformer libraries and for
shape-based filtering within a multi-step structure-based screening protocol in order to shorten
computation times.
Background
Recent advances in the human genomics and proteomics
projects have significantly contributed to the large
number of macromolecular targets entering drug discov-
ery programs. Along the same line, over 10 million
organic compounds are presently available from chemical
vendors and can be used in high throughput screening
(HTS) experiments or in silico computations. However the
escalating costs of both, experimental assays and hard-
ware/software, highlight the need for development of
novel approaches to assist rapid and efficient hit identifi-
cation. Here we focus our attention on structure-based vir-
tual ligand screening (SBVLS) methods [1-4] since they
are known to be effective for library prioritization in the
context of a drug discovery campaign or chemogenomics
initiatives [5-7]. Numerous free or open-source VLS tools
are available to academic groups [8,9] and such in silico
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methods play a major role in facilitating the identification
of new lead compounds.
The ideal SBVLS method should predict both, the pose
and the affinity of the ligands and be able to deal with
flexibility [10]. Such tool does not exist today and trying
to dock millions of molecules on thousands of targets
with the available flexible docking methods eventually
followed by real computations of binding affinities is out
of reach to most research groups. In fact, one may wonder
about the rational of docking/scoring millions of com-
pounds with, for instance, highly CPU demanding sto-
chastic methods (i.e., they may need several independent
runs), into binding pockets for which maybe half (or
more) of the molecules can not fit. Although complemen-
tary physical-chemistry features are of major importance
in determining protein-ligand binding affinity, shape
complementarity is also essential [11,12] indicating that
rigid body docking programs should be revisited. Further-
more, the current trend is to use high-quality [13] target-
focused libraries instead of huge compound collections in
SBVLS or HTS projects as active compounds tend to be
hidden by the noise of the database [14,15]. Clearly, in
SBVLS projects, it seems reasonable to focus the chemical
space of the compound libraries according to geometric
restraints dictated by receptor-binding site [16] prior to
dock/score all the compounds of a database into a bind-
ing pocket via flexible methods. A number of tools and
protocols (i.e., multi-step SBVLS protocols) exploit this
notion of rigid-body docking or at least use approaches
that analyze the shape or the shape complementarity
only, as a first step of a hierarchical procedure, to rapidly
reduce the size of the compound collections prior to using
more accurate and time consuming docking/scoring com-
putations [16-21].
Several methods for performing shape complementarity
search between a ligand and its receptor have been devel-
oped. One of the first programs for protein-small mole-
cule interaction involving shape complementarity search
by rigid body docking was DOCK, developed by Kuntz
and co-workers [22]. The program DOCK generates a neg-
ative image of the receptor by making use of spheres that
fill the binding pocket. The algorithm then attempts to
superimpose the ligand atoms onto the centers of the
spheres. A matching between the ligand and the receptor
by a superimposition of ligands atoms onto the receptor
surface was also employed in [23]. Other programs per-
forming rigid-body docking between small molecules and
proteins are FLOG [24], CLIX [25] and FRED [26]. This
latter applies a Gaussian shape fitting function to opti-
mize the contact surface between the ligand and the pro-
tein thereby allowing extremely fast rigid docking
procedure.
Despite obvious limitations, rigid-body docking methods
are interesting because they are much faster than the flex-
ible docking algorithms and because significant noise can
be generated with fully flexible docking of large collec-
tions. A common approach to improve rigid-body dock-
ing accuracy is to employ a library of compounds
containing pre-generated multiple conformers for each
ligand. Indeed, docking of an ensemble of multiple con-
formations of ligands into a receptor site with a modified
version of DOCK demonstrated much better enrichment
as compared to rigid docking with one single conformer
per ligand [27]. In order to use efficiently rigid body meth-
ods, multi-conformer libraries have to be generated, with
well established commercial packages [28,29] such as
Corina/Rotate (Molecular Networks GmbH) (Gasteiger
Research), OMEGA (Openeye Scientific Software), Cata-
lyst [30] or with free tools like FROG [31].
Although rigid-body docking methods are attractive for
hierarchical SBVLS drug discovery projects [16,19,32],
these ones are under-exploited. In this paper we present
the multiple conformation rigid-body docking filter MS-
DOCK that is based on the program DOCK. Our protocol
was tested on seven target proteins with different binding
site properties for its ability to retrieve 65 known inhibi-
tors in a library of 37970 drug-like compounds. The per-
formance of MS-DOCK was additionally validated
through a comparison with the commercial program
OMEGA for multi-conformer generation and the program
FRED for rigid-body docking (i.e., in this study we used
FRED as a shape complementarity filter not for a full
screening procedure). MS-DOCK was able to successfully
decrease the initial compounds collection by 2- or 3-fold
depending on the ligands size (if known) and binding
pocket shape. Such a reduced compound collection
focused on the pocket shape can then be used in a subse-
quent extensive flexible docking phase, either performed
with DOCK or other tools. As a result, our rigid-body
docking approach prioritizes the compounds by selecting
only the molecules that have satisfactory shape comple-
mentarity with the receptor-binding pocket.
Results
MS-DOCK approach
In this work we describe an efficient approach MS-DOCK
based on DOCK to rapidly screen a molecular database
and to enrich the output collection in molecules having
good shape complementarity with a given protein target
binding site. The MS-DOCK approach involves two main
steps: first, generating multiple 3D conformers for the
flexible molecules present in the input chemical library,
this step is performed with the in-house developed tool
Multiconf-DOCK based on the systematic search
approach available in DOCK5 [33]; second, all multiple
conformations are rigidly docked with DOCK6 (see Meth-BMC Bioinformatics 2008, 9:184 http://www.biomedcentral.com/1471-2105/9/184
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ods for details) using the geometric match method on the
rigid protein target.
Multiconf-DOCK: method and implementation
We developed the program Multiconf-DOCK for small
molecule multi-conformer generation that requires as
starting point the 3D structure of each input molecule in
mol2 format. The method is based on a systematic search
for ligand flexibility [34] as implemented in DOCK5. The
3D structure of the molecule is constructed starting from
an anchor segment and the flexible parts are added via an
incremental re-construction approach named "anchor-
first". We used the multiple fragment option to consider
several possible anchor fragments. Conformations were
generated by rotating all single, non-terminal, acyclic
bonds in specified increments. Using the torsion drive
method [34] low energy dihedral values were tried for
each torsion previously defined. In our implementation
we increased significantly the exploration of the confor-
mational space by enlarging the number of allowed posi-
tions. These changes were introduced because it was
demonstrated that the low energy angle values as imple-
mented in DOCK were not sufficient to reproduce the lig-
and-bound conformation as observed in experimentally
determined protein-ligand complexes [16,32]. Thus for
the single bonds between aromatic cycles and sp2 hybrid-
ized atoms, we allowed 6 positions with 45° rotation
increments while the amide bond was kept rigid. The sin-
gle bonds sp2-O.3/S.3 atoms (Tripos atom type) and aro-
matic cycle-O.3/S.3 atoms were also considered to be
rotatable with 45° increments.
Multiconf-DOCK tool can efficiently sample different
conformations of a ligand due to a RMSD cut-off defined
by the user, as well as a RMSD comparison with an exter-
nal conformation. To compute the RMSD between two
different structures, both conformations are superim-
posed by a least-squares fit procedure [35]. The allowed
conformations for each molecule are selected according to
calculated energy involving the van der Waals and Cou-
lomb terms with the Amber force field as implemented in
DOCK5. The energy threshold, like the RMSD, can be
defined by the user. In this study the maximal energy
allowed to accept a conformer was set to be 25 kcal/mol,
in addition an energy threshold of 25 kcal/mol between
the initial single conformation and the generated one was
permitted. For application in the subsequent rigid-body
docking stage 2, we generated up to 50 conformers for
each molecule present in the chemical library with a
RMSD value of 1.0 Å. To write Multiconf-DOCK, we mod-
ified the program DOCK5 written in C++ while the RMSD
and the energy filters as well as changes in the flexibility
parameters mentioned above were additionally imple-
mented. Multiconf-DOCK is operational on Linux and
Mac OS X systems.
Assessment of multiple conformation generation by Multiconf-DOCK 
and OMEGA
In order to evaluate our conformer generator Multiconf-
DOCK, we used two validation sets. The first tests with
Multiconf-DOCK and OMEGA were performed on 100
chemical compounds obtained from the NMRshift data-
base. The distribution of rotatable bonds of these mole-
cules is shown in Figure 1 (i.e. these compounds contain
several rotatable bonds). The calculated RMSD between
the best conformation generated by Multiconf-DOCK and
OMEGA for series of up to 50 conformers and the pre-
dicted NMR structure versus the number of rotatable
bonds for these 100 molecules are shown in Figure 2. The
average RMSD between the best fitting conformer gener-
ated by Multiconf-DOCK and OMEGA and the test set was
calculated to be 1.1 Å and 0.9 Å, respectively. The results
obtained with both programs are satisfactory since the
RMSD between all saved generated conformers was cho-
sen to be 1.0 Å. As can be expected the ability to generate
a conformation close to structures present in the NMR-
shift database is depending on the number of rotatable
bonds (Figure 2). The RMSD between the best conforma-
tions generated with Multiconf-DOCK and NMRshift
structures for 89% of the molecules with 1–9 rotatable
bonds ranges from 0.1 to 1.5 Å while for 58% of the mol-
ecules with 10–15 rotatable bonds the RMSD are more
than 1.5Å.
We also investigated the Multiconf-DOCK performance
on the bioactive conformations of our second test set (see
Methods section). We assessed the impact of changing the
parameters dealing with flexibility by calculating the
RMSD to experimental structures and by visual inspec-
tion. The goal here was to check whether or not Multiconf-
DOCK was able to reproduce correctly the experimental
bound conformation for the active molecules of our target
proteins. The averaged RMSD between the ligand crystal
structures and the best conformations generated by Multi-
Rotatable bond distributions of 100 test chemical com- pounds from the NMRSHIFT collection Figure 1
Rotatable bond distributions of 100 test chemical 
compounds from the NMRSHIFT collection.
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conf-DOCK and OMEGA (maximum of 50 conformers
per compound) for 36 PDB protein-ligand crystal struc-
tures (out of all 65 known actives) are calculated to be
1.32 Å and 1.30 Å, respectively. The best conformers gen-
erated by Multiconf-DOCK and OMEGA showed RMSD
lower than 1.5 Å for 77% and 75% of the 36 X-ray struc-
tures, correspondingly. The worst RMSD of 2.45 Å was
obtained for two FX inhibitors (PDB codes 1lpk for Mul-
ticonf-DOCK and 1g2l for OMEGA). A possible reason for
this large RMSD could be the accuracy of the bioactive
conformations. For the ligand in the 1lpk.pdb structure
(resolution 2.20 Å) two conformations A and B are sug-
gested. We computed a best RMSD value of 2.45 Å and of
1.23 Å with the conformations A and B, respectively. As
recently discussed by Hawkins et al. [36], inaccuracies of
some ligand structures in X-ray protein-ligand complexes
have been noticed and can be due to numerous reasons,
ultimately leading to high RMSD when compared to mod-
eled ligands conformations. In the case of 1g2l.pdb with a
resolution of 1.9 Å the reason may be elsewhere. The 1g2l
ligand is extremely flexible with 12 rotatable bonds, and
it is known that structural prediction accuracy drops as the
number of rotatable bond increases. Also, generating
more conformers could be valuable for such compound,
additional tests performed with OMEGA and up to 100
conformers improved the result with a best RMSD value
of 1.7 Å. Finally, both programs were able to retrieve the
36 bioactive conformations with an averaged RMSD value
below 1.3 Å (with a maximum of 50 conformers per lig-
and). This RMSD value can be considered as acceptable
for the generation of a "good" docked pose via rigid body
docking. According to the computed RMSD values and
visual analysis (see Additional file 1) both Multiconf-
DOCK and OMEGA explore quite well the conforma-
tional space and are able to generate conformations that
are close to the ligand co-crystal structure.
RMSD between the best-fitted conformers (for series of up to 50) and the NMR structures versus the number of rotatable  bonds for 100 chemical compounds Figure 2
RMSD between the best-fitted conformers (for series of up to 50) and the NMR structures versus the number 
of rotatable bonds for 100 chemical compounds.   for conformers generated by Multiconf-DOCK;   for conformers 
generated by OMEGA.
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Further we applied Multiconf-DOCK to generate multi-
conformer structures for the rigid docking stage 2 of our
MS-DOCK VLS protocol. Our previous analysis [16]
showed that an optimal balance between speed, accuracy
and structural diversity of the final multi-conformer data-
bank implies to generate about 50 conformers per com-
pound with a RMSD value of 1.0 Å. Thus, we saved up to
50 conformers per compound for the 37970 small mole-
cules present in our decoy library. This yielded a total of
709233 conformers (in average 19 conformers per com-
pound) generated by Multiconf-DOCK (90 h in total)
while when computations were carried out with similar
parameters with OMEGA, 825250 conformers (in average
22 conformers per compound) were generated (12 h in
total).
Shape filtering with rigid-body docking by MS-DOCK
We then investigated whether MS-DOCK was able to
retrieve the active compounds (see Table 1) out of a decoy
drug-like library of 37970 molecules against seven protein
targets: ribonuclease A (RNAse), coagulation factor X
(FX), estrogen receptor (ER), CDK2 (CDK), thymidine
kinase (TK), carboxypeptidase A (CBXpe) and neuramini-
dase (NA). Since it is well known that the performance of
SBVLS methods depends on the nature of the receptor
binding sites [37-39], we selected proteins with various
physico-chemical properties of the binding site areas. Our
validation targets can be divided into three groups
depending on the pocket shape and accessibility: 1) with
extremely open and flat binding site: NA with 30% degree
of burial (computed as explained in [16]) and volume of
about 504 Å3 (computed using Q-SiteFinder [40]); 2) sol-
vent-exposed grooves with some deep subpockets: with
degree of burial <47% and volumes as follows: RNAse,
CDK2 (511 Å3) and FX (546 Å3); 3) with a rather closed
and deep binding pockets and high degree of burial (75%-
90%): ER (572 Å3), CBXpe (342 Å3) and TK (456 Å3). Sim-
ilarly to the binding pockets, the actives of the seven tar-
gets also display different physico-chemical properties
(with two being of major importance in the present study:
molecular weight and volume, see Table 1).
We rigidly docked the multi-conformer database gener-
ated by Multiconf-DOCK on each target and investigated
how much we could reduce the input collection while
retaining the active molecules. The enrichment graphs for
the seven protein targets obtained by screening with MS-
DOCK the library of 37970 drug-like chemical com-
pounds with in multi-conformer states generated by Mul-
ticonf-DOCK, are presented in Figure 3. Following the
MS-DOCK computations, the rigid body docking experi-
ments with DOCK6 were performed with our optimized
parameters using the contact scoring function (see Meth-
ods). Two simulations were carried out: one with a bump
filter (the number of maximum allowed bumps sets to 8
which can be considered as quite permissive, allowing for
some atomic clashes, as sometimes required for rigid
body docking) and one without bump filter. Since no
important differences were noticed, here we show only
the enrichment graphs with the applied bump filter. Our
preliminary tests with three different values (50 by
default, 30 and 0) for penalty of each contact clash (see
Methods for details) showed best performance with a con-
tact clash penalty of 30. Thus, all present results with MS-
DOCK are obtained with a clash penalty of 30 per bump.
In an attempt to better take into account the important
structural/chemical differences seen in the ligands and the
binding pockets, we tested 3 possible allowed bump over-
laps from 0.5 to 0.75. A lower clash bump overlap param-
eter tolerates relatively close contacts between the ligand
and the receptor atoms. One can expect that larger ligands
will tend to generate more clashes, keeping in mind that
the procedure involves rigid-body docking. Clearly, the
tuning of the scoring/docking methods according to the
nature of the binding sites/ligands can improve the per-
formance of VLS experiments [16,41]. The results with
MS-DOCK shown in Figure 3 are in agreement with this
line of reasoning. Satisfactory enrichment was achieved in
the case of CDK with the three values of the clash bump
overlap. For the proteins RNAse, ER, and FX, displaying
binging sites with a large volume and binding relatively
large inhibitors (see Table 1), the best results are observed
with the more permissive clash bump overlap of 0.5 (Fig-
ure 3, in cyan). In contrast, when much smaller inhibitors
are active, for instance for TK, CBXpe and NA, the pre-
ferred clash bump overlaps is 0.75 (Figure 3, in green). For
example we evaluated the ratio Volume of the ligand/Vol-
Table 1: Physico-chemical properties of the actives for the seven targets
Protein No. of heavy atoms Molecular weight No. of rotatable bonds Volume (Å3)
RNAse (8 actives) 21 – 50 322 – 791 4 – 14 253 – 613
FX (9 actives) 29 – 41 427 – 548 5 – 12 411 – 616
ER (10 actives) 29 – 45 390 – 458 7 – 15 450 – 483
CDK (10 actives) 18 – 31 241 – 449 1 – 7 250 – 447
TK (10 actives) 13 – 21 186 – 369 4 – 7 181 – 243
NA (10 actives) 17 – 25 237 – 350 4 – 10 236 – 376
CBXpe (8 actives) 12 – 16 121 – 290 2 – 5 108 – 177BMC Bioinformatics 2008, 9:184 http://www.biomedcentral.com/1471-2105/9/184
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Enrichment graphs for 7 protein targets and the 37970-compound collection Figure 3
Enrichment graphs for 7 protein targets and the 37970-compound collection. The percentage of the ranked chemi-
cal library after multi-conformers rigid docking is plotted against the percentage of the retrieved known actives. Results are 
shown for the seven proteins after MS-DOCK with allowed bump overlaps of: 0.5 (in cyan), 0.6 (in magenta), 0.75 (in green). 
The yellow lines represent the results with FRED.
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ume of the pocket using Q-SiteFinder [40] to be 0.95 for
FX 1f0r.pdb and 0.45 for TK 1e2k.pdb. Thus, applying a
clash overlap of 0.5 for large inhibitors (FX, ER, RNAse)
and 0.75 for small inhibitors (TK), at least 70% of the real
actives are retrieved with the MS-DOCK method in the top
30% of the ranked database after the multi-conformer
rigid docking/contact scoring step. For NA and CBXpe
(with ratio Volume of the ligand/Volume of the pocket of
0.44 and 0.42, respectively) we still note acceptable results
with MS-DOCK. In the top 40% of the shape-scored data-
base, 50% of the actives are retrieved.
One obvious question arises at this stage of our analysis:
if no information is available about active ligands for a
given target, which parameters should be used for efficient
reduction of the database via rigid-body docking with MS-
DOCK? In such a case we suggest a bump clash overlap of
0.6 since the results (see Figure 3, in magenta) for five tar-
gets FX, RNAse, ER, CDK and TK show an overall good
enrichment with 80% of the actives retrieved in the top
~50% (enrichment factor of 1.6). Forty per cent are
retrieved in the top 50% for NA and CBXpe (enrichment
factor of 0.8). As final results, after applying MS-DOCK
with parameters adapted to the binding pocket and the
size of the ligands, the chemical library can be successfully
reduced by 2- to 3-fold, thus computational time can be
significantly decreased for a subsequent flexible docking
step.
Shape filtering with rigid-body docking by FRED
In order to further evaluate MS-DOCK, similar shape fil-
tering computations were performed with FRED while the
multi-conformer library was generated with OMEGA. The
results for the seven proteins are shown in Figure 3 (in yel-
low). For the proteins FX, RNAse, ER, CDK, and CBXpe
similar results were obtained with different box sizes
defining the search zone. The enrichments achieved with
a box extension of 4 Å around a reference ligand are
shown in Figure 3. In the cases of TK and NA, the best
results were obtained with a box of 2 Å around the refer-
ence ligand (Figure 3). While FRED is extremely efficient
for FX and ER (retrieving the actives in the top 10% of the
bank), it fails for NA, TK, and CBXpe. The shapegauss
scoring function with applied "Optimization" is not able
to rank properly the relatively small active compounds of
TK, NA, and CBXpe.
Discussion
Recent successful applications of SBVLS for hit discovery,
lead optimization and target-based library design have
been reported [15] but most of the different steps can be
optimized. Here we suggest that shape-matching tools
able to rapidly reduce the size of the input library are of
importance not only to save CPU time but also to enhance
the performance of the overall docking-scoring methods
[16,20]. Along this line of reasoning, recent studies under-
line the need of using target specific libraries since active
compounds can be obscured by the vast noise of a large
database in which they are contained (see for instance
Orry et al. [14]). To overcome the exponential problem
inherent to flexible ligand docking methods, one can per-
form rigid-body docking with multiple conformer librar-
ies as input and shape complementarity search as a first
filtering step of a hierarchical procedure. Such protocol
should be able to rapidly dock a large number of mole-
cules, filtering out in a relatively "crude" way irrelevant
compounds while the molecules fitting well in the bind-
ing pocket can be passed to a next, more precise, flexible
docking-scoring stage. Although some commercial or pro-
prietary packages able to perform rigid body docking are
available, it is important to offer free-of-charge programs
(like DOCK, Multiconf-DOCK and MS-DOCK) to aca-
demic scientists working in the field of drug discovery
since funding can be rather limited in many institutions.
On the other hand, neglecting receptor flexibility in VLS
protocols [42] can be problematic when dealing with
some targets (i.e., induced fit [43] or enhanced flexibility
at the protein-protein interfaces [44]). Recently, several
studies have been published suggesting various strategies
to treat receptor flexibility in VLS studies [43,45,46]. How-
ever, this is very challenging because the number of possi-
ble conformations rises exponentially with the number of
rotatable bonds and the full sampling of all possible con-
formations is not achievable at present at the initial phase
of a project when dealing with thousands of compounds.
As such, many approaches implement pseudo-flexibility
from the receptor side, these ones may or may not lead to
better enrichment [47]. However, the purpose of MS-
DOCK is to allow for a fast shape based pre-filtering step
and it is not intended to directly treat the flexibility of the
binding pocket. Yet, MS-DOCK can be easily applied on
multiple receptor conformations generated either through
simulations (for instance by normal mode analysis or
molecular dynamics/Monte Carlo simulations [48]) or
experimentally (several NMR or X-ray structures [21]).
Lorber and Shoichet have also [27] proposed to dock rig-
idly hierarchical databases containing ligands in a multi-
ple-conformer state. One problem of using their approach
is the absence of treatment of the ligand's internal energy.
Therefore, this protocol can easily lead to unrealistic lig-
and conformations (for instance important internal lig-
and clashes may be present) fitting apparently well into
the binding pocket while being indeed a computational
artifact. This in turn increases the noise of the ranked data-
base because some compounds that can not fit into the
binding pocket are still selected and may indeed have a
very favorable binding score. On the contrary, generating
multiple ligand conformations within a reasonableBMC Bioinformatics 2008, 9:184 http://www.biomedcentral.com/1471-2105/9/184
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energy window (not necessarily only the lowest energy
conformations) like with Multiconf-DOCK or OMEGA
prior to rigid-body docking allows for the selection of rel-
evant ligand conformations. In [23] the authors proposed
to dock multiple ligand conformers generated by random
increment of 120° to the dihedral angles on a rigid recep-
tor. In a different way, our treatment of rotatable bonds by
a systematic search with increased flexibility in Multiconf-
DOCK (see details in the Results section: Multiconf-DOCK:
method and implementation) permits better exploration of
the ligand conformational space but still within an
allowed energy window. Our proposed Multiconf-DOCK
tool was capable to generate conformations close to pre-
dicted NMR structures of small molecules (see Figure 2).
For 80% of the test compounds with up to 15 rotatable
bonds, the best fit to the experimental structure showed
RMSD values lower than 1.5 Å. In addition, it was also of
major importance to test Multiconf-DOCK for its ability
to generate conformations similar with bioactive confor-
mations (see Additional file 1) because one goal of the
present study is to propose a geometric filter able to
reduce the size of the input chemical library. The averaged
RMSD of 1.3 Å between the best fitting predicted struc-
tures and the experimental crystal structures for the 36
actives proves that the changes that we have introduced in
the parameters increasing ligand flexibility whenever
appropriate. As mentioned above, we stress the attention
of the readers to the fact that with the default low-energy
dihedral angles implemented in DOCK5, a number of lig-
and conformations bound to a protein could not be
reproduced [16,32]. Indeed, it is known that when a lig-
and binds to a protein, it is typically not in the lowest-
energy conformation [49,50]. One of the factors deter-
mining high strain energies in bound ligands may be the
process of unfolding, in which the intramolecular interac-
tions between hydrophobic groups in ligands are released
to increase the interactions with the protein binding site
as suggested in [49].
After analysis of the conformer generation step, we evalu-
ated the performance of MS-DOCK and FRED (ran in its
shape-complementarity mode only to make the present
comparison meaningful) to retrieve known actives seeded
in a drug-like library of 37970 molecules for seven target
proteins with various binding site geometries and proper-
ties. FRED is very efficient when large ligands are bound
in a relatively large binding site as in the cases of ER,
RNAse, CDK and FX. On the contrary, the FRED shape-fil-
tering search failed when relatively small ligands are
bound in the pocket (the cases of TK, CBXpe and NA). MS-
DOCK showed good results for ER, RNAse, FX, CDK and
TK, allowing to keep only the top 30% of the initial
library. For NA and CBXpe, because the inhibitors are
small and the active sites are relatively large, MS-DOCK
does not perform very well, yet the results are acceptable.
In such cases 50% of the ranked database should be con-
sidered for subsequent more precise flexible docking
experiments. In terms of speed, MS-DOCK screened our
collection containing 709233 conformations in 70 h with
on average for the seven targets (2.8 conformers per sec;
~10 ligands per min), on one CPU compared to 1 ligand
per min for flexible ligand docking with DOCK. Thus the
MS-DOCK method is 10-fold faster than the standard flex-
ible ligand docking with DOCK and it can speed up con-
siderably the VLS process, allowing a reduction of at least
2-fold the subsequent flexible docking step. All computa-
tions in this study were carried out on two Linux worksta-
tions (Xeon 3.0 GHz and 1.5 Gb RAM). Averaged on the
seven targets, FRED screened the database of 825250 con-
formations in 30 h. On average, FRED docked 8 conform-
ers per second on the same computer and is thus 3 times
faster than MS-DOCK. Yet, while FRED achieves faster
rigid-body docking, MS-DOCK shows a better overall per-
formance for the purpose of creating target specific librar-
ies based on shape complementarity only.
Conclusion
We have developed MS-DOCK to rapidly screen a large
compound collection for the generation of "focused"
libraries of reduced size containing molecules with satis-
factory shape complementarity with the receptor binding
pocket. MS-DOCK employs the in-house developed tool
Multiconf-DOCK for multiconformer library generation.
In addition, better handling of ligand flexibility as imple-
mented in Multiconf-DOCK can easily be employed to
improve the docking accuracy of flexible docking with
DOCK6.
The MS-DOCK method, which is based on the widely
used program DOCK (both free-of-charge for academic
institutions) tends to perform better than FRED when this
one is applied as geometric filters at least on our valida-
tion set. Depending on the target-binding site, MS-DOCK
allows the use of a fraction of the initial databank (typi-
cally 30–50%) without compromising the performance of
the protocol in retrieving actives.
We argue that multi-stage SBVLS can help to improve the
speed and rate in the search of hit compounds with new
scaffolds. Applying shape filtering as a first step of a struc-
ture-based screening protocol can result in the creation of
target-specific libraries without decreasing the chemical
diversity of the selected compounds. In this line of reason-
ing the MS-DOCK method can successfully be applied as
a part of a hierarchical VLS procedure in order to lower the
length of the computations while improving the perform-
ance of the overall procedure.BMC Bioinformatics 2008, 9:184 http://www.biomedcentral.com/1471-2105/9/184
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Methods
Preparation of the validation sets
Target structures
Seven protein targets were chosen with diverse binding
site properties. Crystal structures of estrogen receptor (ER,
PDB code 3ert, resolution 1.90 Å), thymidine kinase (TK,
PDB code 1kim, resolution 2.14 Å), coagulation factor X
(FX, PDB code 1f0r, resolution 2.10 Å), ribonuclease A
(RNAse, PDB code 1afk, resolution 1.70 Å), neuramini-
dase (NA, PDB code 1b9s, resolution 2.50 Å), CDK2
(CDK, PDB code 1fvv, resolution 2.80 Å), and carbox-
ypeptidase A (CBXpe, PDB code 1hdq, resolution 2.30 Å)
were selected for the VLS experiments. For each target we
retrieved from the PDB [51] up to ten X-ray holo struc-
tures with resolution from 1.20 Å to 2.80 Å. The final
selection of the receptor structures for the VLS experi-
ments was done by analysis of the binding sites in the
retrieved protein-ligand complexes since upon ligand
binding conformational changes of receptors can occur,
from 'large-scale' loops to single side-chain movements
[48]. The superimposition of the structures showed prac-
tically identical 3D structures for FX and NA. In the cases
of TK and ER, for some of the X-ray structures, several res-
idues next to the binding pockets were missing, thus we
selected the best and more complete X-ray structures.
Interestingly, for three of the targets, conformational dif-
ferences in/close to the binding sites were present, namely
for RNAse (side-chains movements), CDK (a loop move-
ment) and CBXpe (with pocket volume depending on the
bound ligands). For these three proteins we chose the
most open binding pockets among the several crystal
complexes available at the PDB. For all proteins the water
molecules and ligands were removed from the binding
sites. Hydrogen atoms were added to protein structures
using the program InsightII [52]. The seven proteins and
corresponding ligands structures used in this study can be
downloaded from our website [53].
Compound library
The chemical library for our VLS experiments can be
found at the RPBS web server [54] in the section FAF-
Drugs [55,56]. Our testing set is based on the 2004 release
of the ChemBridge Diversity set database. The 50080 mol-
ecules were first filtered in order to remove non-drug like
compounds using the program FILTER version 1.0.2 [57]
with a slightly modified filtering parameter file. The main
parameters that were modified are: molecular weight
(min/max) 100 Da/900 Da; number of carbons (min/
max) 5/35; rotatable bonds (min/max) 0/20; hydrogen
bond donors/acceptors (max) 8/12, sum formal charges
(min/max) -2/2; XlogP (min/max) -5/6; 2D polar surface
area (min/(max) 0/160 Å 2; and rejection of about 100
toxic/reactive functional groups. The resulting ADME/Tox
filtered library contained 37970 compounds. To this col-
lection we added the 65 active inhibitors of the seven tar-
get proteins, all in SMILES format. These molecules were
transformed in 3D (single conformer) using the program
OMEGA v.2.
Validation compounds sets for multiple conformation generation
One testing set for the validation of our Multiconf-DOCK
tool (multiple conformer generation) was downloaded
from the NMRSHIFT website [58,59]. This collection con-
tains predicted 3D structure of small molecules carried
out with a structure-coding scheme correlating structural
features with chemical shift values. We chose randomly
130 small molecules to investigate Multiconf-DOCK and
removed from this list molecules that did not contain any
rotatable bonds. One hundred small chemical com-
pounds with various numbers of rotatable bonds (see Fig-
ure 1) were finally used to investigate our multiple 3D
conformers generator. The same 100 compounds were
subjected to multiple conformation generation with
OMEGA. We also generated a second validation set by
extracting 36 ligands (out of the 65 actives of our targets)
from X-ray protein-ligand structures with resolution from
1.20 Å to 2.60 Å. These two sets of 100 and 36 chemically
diverse compounds were used to assess OMEGA and Mul-
ticonf-DOCK. The physico-chemical properties of both
validation compounds sets were assessed via the ADME/
tox filtering tool FAF-Drugs [55,56] available on the RPBS
web server [54]. The ligand volumes were computed with
InsightII [52].
Shape filtering by rigid-body docking with MS-DOCK
MS-DOCK employs a rigid-body docking method as
implemented in DOCK6. It aims at performing a fast
"geometric" filtering selection of ligands that fit well in
the binding pocket using only a surface complementarity
criterion. DOCK fits the multiple rigid conformers into
the rigid receptor by calculating an orientation for each
conformer in the binding site, and then by evaluating the
fit. We applied the sphere method of Kuntz [22] to iden-
tify pseudo-atom positions of a ligand in the receptor.
DOCK uses spheres representing a negative image of the
receptor-binding site and ligand heavy atom centers to rig-
idly orient ligands in the receptor. We used the program
DMS [60] to compute the molecular surface of the recep-
tor. The overlapping spheres within a radius of 4 Å were
generated on the protein binding site surface with the pro-
gram SPHGEN [61]. Sphere clusters within 6 Å to a ligand
reference were retained for all our protein targets but for
NA that possesses an open and flat binding site. For this
target, the distance was limited to 4 Å in order to diminish
possible noise most created by very large compounds arti-
ficially fitting to the very flat binding site. For orientation
of the ligands in the binding sites both automated and
manual match algorithms are available in DOCK6, they
proceed through matching of all receptor sphere pairs to
ligand's atom pairs. While the automated matching gener-BMC Bioinformatics 2008, 9:184 http://www.biomedcentral.com/1471-2105/9/184
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ates matches until the chosen maximum number of orien-
tations is reached (thus equal number of orientations for
all molecules), the manual matching generates only the
matches which satisfy user defined distance (intra-ligand
or intra-receptor distances allowed in a match) and node
(numbers of atom-site point interactions needed to con-
struct an orientation) parameters. In this way, when the
manual matching is applied, ligands with more similar
internal distances with the receptor site points will be pri-
oritized. Finally a smaller number of orientations com-
pared to the automated matching will be scored reducing
computational time. In order to speed up the calculations,
we applied manual match (the parameters are given in the
Additional file 2) with a limit of a maximum 500 orienta-
tions.
The generated orientations of the different conformers are
scored in order to evaluate the degree of fit with the recep-
tor. In our calculations, the score measures only the steric
complementarity by use of the simplest and fastest con-
tact scoring function. The contact score procedure availa-
ble in DOCK adds up the number of receptor atoms
within a prescribed distance range (4.5 Å by default)
defining potentially attractive interactions. If the two
atoms approach close enough to clash as identified with
the bump grid, then the interaction can be penalized. We
tested three different allowed bump overlaps (amount of
van der Waals overlap; for a value of 1 no overlap is
allowed): 0.75 (default), 0.60 and 0.50. In addition three
different values of contact clash penalty per atom bump
were tested: 50 (default), 30 and 0. We carried out rigid-
body docking on seven protein targets with multiple con-
formations pre-generated with Multiconf-DOCK for all
molecules of the database. The key MS-DOCK input
parameters can be seen in the Additional file 2.
Generation of multiple conformations by OMEGA
The algorithm implemented in OMEGA v.2 (Openeye Sci-
entific Software) dissects the molecules into fragments
and uses fragment templates to build a seed conformation
(see [57]). Next OMEGA begins torsion search with an
assessment of freely rotatable bonds. Conformers are gen-
erated and are associated with a strain energy evaluated
using the Merck molecular force field. The termination cri-
teria to generate conformers can be the total number of
generated conformers decided by the user. One key
parameter is the ewindow value which defines the strain
energy range within which conformers are considered as
acceptable (the default ewindow was set to 25.0 kcal/
mol). Next to ewindow, the parameter RMSD plays also a
major role as it sets the minimum root mean square devi-
ation of coordinates below which two conformers are
considered to be identical. In our computations and fol-
lowing results from the literature, we generated a maxi-
mum of 50 conformations per molecule and used an
ewindow of 25.0 kcal/mol and an RMSD cutoff of 1.0 Å
[28]. We used this large RMSD value to ensure adequate
conformational sampling and important structural diver-
sities, while the large ewindow value was chosen because
in many cases the conformation adopted by small com-
pounds co-crystallized into a protein-binding site can be
relatively far from global minimum energy conformations
[49,50].
Shape filtering by rigid-body docking with FRED
FRED 2.1 [26] (Openeye Scientific Software) was used in
this study to dock the OMEGA pre-generated multi-con-
former library mentioned above. FRED 2.1 strategy is to
exhaustively dock/score all possible positions of each lig-
and in the binding site. The exhaustive search is based on
rigid rotations and translations of each conformer within
the binding site defined by a box created by the users.
FRED filters the poses ensemble by rejecting the ones that
clash with the protein or that do not have enough contacts
with the receptor. The final poses can then be scored or re-
scored using one or more scoring functions. In this study
we decided to select the smooth shape-based Gaussian
scoring function (shapegauss) to evaluate the shape com-
plementarity between each ligand and the binding pocket.
The reason for this choice is that this protocol is then com-
parable to the MS-DOCK rigid-body docking protocol
described above while the search approach and the scor-
ing differ. We used the default FRED protocol except for
the size of the box defining the binding sites. In an
attempt to optimize the docking-scoring performance we
performed exhaustive docking with shapegauss applying
the "Optimization" mode. The "Optimization" mode
involves a systematic solid body optimization of the top
ranked poses from the exhaustive docking. We explored 3
different boxes: for each protein three different simula-
tions were carried out with an added value of 6, 4 (by
default) or 2 Å around the reference ligand.
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